Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.114024 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Artur Antosel und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Antosel, A., Ceban, Z., Robu, M., Buruiana, S., Dudnic, C., & Tomacinschii, V. (2026). Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.114024
Vancouver
Antosel A, Ceban Z, Robu M, Buruiana S, Dudnic C, Tomacinschii V. Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.114024
BibTeX
@article{Antosel2026,
author = {Antosel, Artur and Ceban, Zinaida and Robu, Maria and Buruiana, Sanda and Dudnic, Cristina and Tomacinschii, Victor},
title = {Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.114024}
}
EUVIMED